| Net loss | 137.93M |
| Depreciation and amortization | 86.9M |
| Amortization of deferred loan costs | |
| Deferred income taxes | -124.79M |
| Bad debt expense | 35K |
| Net non-cash income from discontinued operations | |
| Stock compensation expense | 7.73M |
| Net gain on sales of assets | -5.16M |
| Receivables | -144.34M |
| Inventories | -62.01M |
| Other current assets | |
| Other assets and liabilities | |
| Accounts payable | |
| Accrued expenses | -35.12M |
| Net cash used in operating activities | |
| Purchases of property, plant and equipment | -34.13M |
| Proceeds from sale of property, plant and equipment | 2.82M |
| Net cash used in investing activities | |
| Payments of long-term debt and other loans | -755.1M |
| Proceeds from rights offering | 0 |
| Payment of recapitalization costs | |
| Repurchase of common stock | -1.09M |
| Net cash provided by (used in) financing activities | |
| Net change in cash and cash equivalents | -59.21M |
| Cash and cash equivalents at beginning of period | 65.06M |
| Cash and cash equivalents at end of period | 5.85M |